Colgate-Palmolive (NYSE:CL) PT Raised to $85.00

Colgate-Palmolive (NYSE:CL) had its price objective boosted by equities research analysts at Barclays from $84.00 to $85.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target suggests a potential downside of 6.07% from the company’s current price.

Several other equities research analysts have also recently weighed in on CL. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. Citigroup increased their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Bank of America boosted their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday. UBS Group upped their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Finally, Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price on the stock in a research report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $91.44.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $90.49 on Tuesday. The firm has a market capitalization of $74.38 billion, a PE ratio of 28.64, a PEG ratio of 3.42 and a beta of 0.42. The company has a current ratio of 0.42, a quick ratio of 0.28 and a debt-to-equity ratio of 8.59. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $92.25. The firm’s fifty day simple moving average is $87.80 and its 200 day simple moving average is $81.77.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the business posted $0.73 earnings per share. The firm’s revenue was up 6.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.5 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 232,371 shares of company stock worth $19,505,099. Insiders own 0.37% of the company’s stock.

Institutional Trading of Colgate-Palmolive

Institutional investors have recently added to or reduced their stakes in the company. Union Savings Bank boosted its position in shares of Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after acquiring an additional 134 shares in the last quarter. PSI Advisors LLC grew its holdings in shares of Colgate-Palmolive by 4,971.4% during the 1st quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after purchasing an additional 348 shares during the last quarter. OFI Invest Asset Management bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $25,000. Avion Wealth lifted its stake in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at about $32,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.